Controlled Exposures to Air Pollution in Patients With Coronary Heart Disease
NCT ID: NCT00437138
Last Updated: 2007-02-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
EARLY_PHASE1
20 participants
INTERVENTIONAL
2006-04-30
2006-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Cardiovascular Effects of Air Pollution: the Role of Nitric Oxide
NCT00845767
The Cardiovascular Effects of Nitrogen Dioxide Exposure
NCT00774514
The Effects of Diesel Exhaust Inhalation on Vascular Function - the Role of Endothelin
NCT00745693
Biodiesel Exhaust, Acute Vascular and Endothelial Responses
NCT01337882
The Effects of Diesel Exhaust Inhalation On Exercise Capacity In Patients With Stable Angina Pectoris
NCT00737958
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In a double blind randomized cross-over study, 20 patients with prior myocardial infarction will be exposed to dilute diesel exhaust (300µg/m3) or filtered air during periods of rest and moderate exercise in a controlled exposure facility. During the exposure, myocardial ischemia will be quantified by ST-segment analysis using continuous 12-lead electrocardiography. Six hours following exposure, vascular vasomotor and fibrinolytic function will be assessed by means of intra-arterial agonist infusions.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exposure to dilute diesel exhaust (300µg/m3) or filtered air
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* On standard secondary preventative therapy
Exclusion Criteria
* History of arrhythmia
* Diabetes mellitus
* Uncontrolled hypertension
* Renal or hepatic failure
* Unstable coronary disease (acute coronary syndrome or unstable symptoms within 3 months)
* Occupational exposure to air pollution
* Current smokers
* Asthma
* Inter-current illness
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Umeå University
OTHER
University of Edinburgh
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David E Newby, MD
Role: PRINCIPAL_INVESTIGATOR
University of Edinburgh
Thomas Sandstrom, MD
Role: PRINCIPAL_INVESTIGATOR
Umeå University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Umeå University
Umeå, Västerbotten County, Sweden
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Langrish JP, Watts SJ, Hunter AJ, Shah AS, Bosson JA, Unosson J, Barath S, Lundback M, Cassee FR, Donaldson K, Sandstrom T, Blomberg A, Newby DE, Mills NL. Controlled exposures to air pollutants and risk of cardiac arrhythmia. Environ Health Perspect. 2014 Jul;122(7):747-53. doi: 10.1289/ehp.1307337. Epub 2014 Mar 25.
Mills NL, Tornqvist H, Gonzalez MC, Vink E, Robinson SD, Soderberg S, Boon NA, Donaldson K, Sandstrom T, Blomberg A, Newby DE. Ischemic and thrombotic effects of dilute diesel-exhaust inhalation in men with coronary heart disease. N Engl J Med. 2007 Sep 13;357(11):1075-82. doi: 10.1056/NEJMoa066314.
Related Links
Access external resources that provide additional context or updates about the study.
Centre for Cardiovascular Science, Edinburgh
British Heart Foundation
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RG/05/003 DISARM 2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.